Sinphar Pharmaceutical Co. Ltd.(TW:1734)
NT$30.15+0.05 (+0.17%)
TW:1734
Sinphar Pharmaceutical Co. Ltd. financials statements
NT$30.15
At close:+0.05 (+0.17%)
Sinphar Pharmaceutical Co. Ltd. (1734) Income Statement
Sinphar Pharmaceutical Co. Ltd. Income Statement
Last quarter (Q2 2026), Sinphar Pharmaceutical Co. Ltd.'s total revenue was NT$871.15M, an increase of 7.16% from the same quarter last year. In Q2, Sinphar Pharmaceutical Co. Ltd.'s net income was NT$92.57M. See Sinphar Pharmaceutical Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 3.37B | NT$ 3.15B | NT$ 2.96B | NT$ 2.86B | NT$ 2.43B | |
| NT$ 1.46B | NT$ 1.24B | NT$ 1.09B | NT$ 1.09B | NT$ 888.71M | |
| NT$ 1.04B | NT$ 943.01M | NT$ 803.51M | NT$ 893.50M | NT$ 1.07B | |
| Depreciation and Amortization | NT$ 254.33M | NT$ 257.37M | NT$ 243.52M | NT$ 266.71M | NT$ 269.37M |
| NT$ 689.70M | NT$ 601.24M | NT$ 582.94M | NT$ 539.57M | NT$ 109.64M | |
| NT$ 416.86M | NT$ 294.01M | NT$ 286.06M | NT$ 197.80M | NT$ -180.23M | |
| NT$ -15.33M | NT$ 13.24M | NT$ 19.65M | NT$ 47.24M | NT$ -4.29M | |
| NT$ 401.52M | NT$ 307.10M | NT$ 305.71M | NT$ 245.05M | NT$ -184.53M | |
| NT$ 365.75M | NT$ 304.70M | NT$ 375.17M | NT$ 224.64M | NT$ -38.13M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.92 | NT$ 1.68 | NT$ 2.07 | NT$ 1.24 | NT$ -0.21 |
| Diluted EPS | NT$ 1.92 | NT$ 1.68 | NT$ 2.07 | NT$ 1.24 | NT$ -0.21 |
| Weighted Average Shares Outstanding | 184.52M | 181.14M | 181.24M | 181.14M | 181.14M |
| Weighted Average Shares Outstanding (Diluted) | 184.52M | 181.49M | 181.24M | 181.45M | 181.14M |
Currency in TWD
